Segall Bryant & Hamill LLC Boosts Position in HealthEquity, Inc. (NASDAQ:HQY)

Segall Bryant & Hamill LLC increased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 50.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 100,591 shares of the company's stock after buying an additional 33,844 shares during the period. Segall Bryant & Hamill LLC owned 0.12% of HealthEquity worth $8,889,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Ameritas Investment Partners Inc. lifted its position in HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock valued at $3,248,000 after purchasing an additional 88 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in HealthEquity by 0.6% during the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock worth $1,850,000 after acquiring an additional 106 shares during the last quarter. Hancock Whitney Corp boosted its position in HealthEquity by 1.0% during the 4th quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock worth $1,279,000 after acquiring an additional 133 shares during the last quarter. Xponance Inc. boosted its holdings in shares of HealthEquity by 1.1% in the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after buying an additional 136 shares during the last quarter. Finally, Level Four Advisory Services LLC boosted its holdings in shares of HealthEquity by 5.3% in the 4th quarter. Level Four Advisory Services LLC now owns 2,736 shares of the company's stock valued at $263,000 after buying an additional 138 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Price Performance

NASDAQ HQY traded down $0.62 during trading on Monday, reaching $97.08. The company's stock had a trading volume of 693,526 shares, compared to its average volume of 870,969. The stock has a market capitalization of $8.39 billion, a PE ratio of 70.86, a P/E/G ratio of 1.51 and a beta of 0.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The firm has a fifty day moving average of $101.65 and a 200 day moving average of $98.49. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same period in the prior year, the company earned $0.80 EPS. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the sale, the executive vice president owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the sale, the executive vice president owned 75,689 shares in the company, valued at $8,519,553.84. This represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research firms have weighed in on HQY. Raymond James Financial reiterated a "strong-buy" rating and set a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. The Goldman Sachs Group increased their price objective on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. Finally, JMP Securities raised their price target on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research report on Wednesday, June 4th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average target price of $118.55.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.